Success Story: Bangladeshi Neuroscience Postdoctoral Researcher Secures NIW Approval for Vision Loss Therapies

Posted by wegreened on April 29, 2026 in NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

"Thank you very much. I am satisfied with the case presentation.”

On March 4^th, 2026, we received EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Associate in the Field of Neuroscience (Approval Notice).

General Field: Neuroscience

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Nebraska

Approval Notice Date: March 4^th, 2026

Processing Time: 11 months, 15 days (Premium Processing Upgrade Requested)

Case Summary:

North America Immigration Law Group (Chen Immigration Law Associates) recently facilitated the approval of an EB-2 NIW for a Postdoctoral Research Associate from Bangladesh. The client received his approval on March 4th, 2026, after a total processing time of 11 months and 15 days, which was aided by a Premium Processing upgrade.

Combating Vision Loss Through Stem Cell Innovation

The petitioner, an expert in the field of neuroscience, focuses his work on advancing the treatment of retinal degeneration by developing and applying stem cell-based therapies. This critical and highly specialized work involves ex-vivo stem cell transplantation, disease modeling, and the activation of endogenous retinal stem cells.

By targeting the underlying physiological causes of vision loss and blindness, his research is poised to alleviate the severe economic and healthcare burdens associated with these debilitating conditions.

A Record of Exceptional Scholarly Output

We highlighted the client's exceptional academic background, which includes a Ph.D. in medical sciences. We detailed his prolific publication record, demonstrating that his research has resulted in 30 peer-reviewed journal articles. Additionally, his expansive output includes 4 first-authored conference abstracts and 1 first-authored book.

Furthermore, the global scientific community's reliance on her methodologies is staggering. Her publications have been cited a total of 2,453 times by independent researchers around the world. This exceptionally high citation count—placing several of her papers in the top 0.1% and top 1% of the field of Immunology—unequivocally establishes her as a leading voice in cancer research.

Global Influence and Prestigious Funding

The petitioner's discoveries have resonated deeply within the global scientific community. Due to its applicability in the field, his research has accrued a total of 474 citations from independent researchers worldwide. Further evidencing his recognized standing in neuroscience, he has also been entrusted to complete a peer review for a scholarly journal.

Highlighting the overarching importance of his work, we also noted that his studies have been supported with funding from the Japan Society for the Promotion of Science.

By strategically weaving together his advanced degree, high-impact publication metrics, and international funding, we successfully demonstrated that advancing his research in the United States serves the national interest.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%